Collection of epidemiological data on AML: age, initial and prognostic factors, subgroup distributions. Incidence and age distribution are compared with the data from the population-based tumor registers.
Collection of the most important patient-relevant clinical endpoints (outcomes):
recurrence-free survival (RFS)/time to recurrence (TTR), calculation of the cumulative recurrence incidence (CIR) and overall survival (OS)
Collection of epidemiological data on AML: age, initial and prognostic factors, subgroup distributions. Incidence and age distribution are compared with the data from the population-based tumor registers.
Collection of the most important patient-relevant clinical endpoints (outcomes):
recurrence-free survival (RFS)/time to recurrence (TTR), calculation of the cumulative recurrence incidence (CIR) and overall survival (OS)
